COMMUNIQUÉS West-GlobeNewswire

HempAmericana CEO Issues Letter on Shift to Commercial-Stage Operations

10/09/2018 - 14:00

NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- HempAmericana, Inc.(GlobeNewsWire)—via OTC PR WIRE-- (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, [...]

Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS)

10/09/2018 - 14:00

Demonstrating benefit in rPFS versus control, with no detriment to OS, sufficient for full approval A positive assessment on either rPFS or OS is sufficient for full approval rPFS analysis expected late 2019, [...]

BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference

10/09/2018 - 14:00

RALEIGH, N.C., Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial stage specialty pharmaceutical company dedicated to patients living with chronic pain, today [...]

Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors

10/09/2018 - 14:00

BOSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for [...]

Selecta Biosciences to Present at the Janney Healthcare Conference on September 17, 2018

10/09/2018 - 14:00

WATERTOWN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

Novo Nordisk A/S - Share repurchase programme

10/09/2018 - 13:48

Bagsværd, Denmark, 10 September 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Aurora Cannabis to Acquire South American Market Leader ICC Labs

10/09/2018 - 13:30

Transaction Establishes Strong Foundation for Aurora’s South American Growth Strategy in Medical, Adult Consumer Use and CBD Wellness Markets EDMONTON, Alberta and VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE [...]

VIVUS Announces 1-for-10 Reverse Stock Split

10/09/2018 - 13:30

CAMPBELL, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that the Company’s stockholders approved a reverse stock split. Effective [...]

Amryt receives IND approval from FDA for AP101 enabling the opening of US clinical trial sites

10/09/2018 - 13:00

10 September 2018 AIM: AMYT ESM: AYP Amryt Pharma plc (“Amryt” or the “Company”) Amryt receives IND approval from FDA for AP101 enabling the opening of US clinical trial sites Amryt, a biopharmaceutical company focused [...]

Oncolytics Biotech® Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cancer with Pelareorep

10/09/2018 - 13:00

CALGARY, Alberta and SAN DIEGO, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic [...]

Inivata to Present New Clinical Data on the Utility of the InVision® Liquid Biopsy Platform in Advanced Non-Small Cell Lung Cancer (NSCLC) at WCLC 2018

10/09/2018 - 13:00

Inivata to Present New Clinical Data on the Utility of the InVision® Liquid Biopsy Platform in Advanced Non-Small Cell Lung Cancer (NSCLC) at WCLC 2018 Oral presentations and posters to feature Inivata’s InVisionFirst [...]

XORTX Announces Submission of Orphan Drug Designation Application

10/09/2018 - 13:00

Phase II Clinical Study in ADPKD Planned CALGARY, Alberta, Sept. 10, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on [...]

T2 Biosystems to Participate in Two Upcoming Investor Conferences

10/09/2018 - 13:00

LEXINGTON, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Next Chairman of Board of Directors

10/09/2018 - 13:00

WATERTOWN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer

10/09/2018 - 13:00

BERKELEY HEIGHTS, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]

Recro Pharma to Participate in Upcoming Investor Conferences

10/09/2018 - 13:00

MALVERN, Pa., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

10/09/2018 - 13:00

CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, [...]

Auxly Provides Corporate Update and Highlights 2018 Milestones

10/09/2018 - 13:00

VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") is pleased to provide a corporate update in respect of its key [...]

Aleafia Secures First Cannabis Revenue in Sale to CannTrust

10/09/2018 - 13:00

Record Clinic Revenue in Q2 Along With Cannabis Sales to Provide Multiple Immediate Income Streams TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“Aleafia“) or (the “Company [...]